Table 1. Patient characteristics.
Total adults: 35561 | Total children: 2601 | |
---|---|---|
| ||
Number* (%) | Number* (%) | |
| ||
Median age at ART initiation, years | 37, (IQR 30-46) | 4.65, (IQR 1.02-9.75) |
| ||
Sex | ||
Male | 21623 (60.8) | 1299 (49.9) |
Female | 13935 (39.2) | 1302 (50.1) |
Unknown | 3 (0.0) | 0 (0.0) |
| ||
Prior AIDS-defining illness | ||
No | 15508 (43.6) | 164 (6.3) |
Yes | 2695 (7.6) | 52 (2.0) |
Unknown | 17358 (48.8) | 2385 (91.7) |
| ||
Median Pre-ART CD4 count | 218 cells/μL, (IQR 105-344) | 15.89 percent, (IQR 8.70-23.24) |
| ||
HIV mode of exposure | ||
Homosexual/bisexual | 8537 (24.0) | 0 (0.0) |
Heterosexual | 14216 (40.0) | 0 (0.0) |
IDU | 1639 (4.6) | 0 (0.0) |
Perinatal | 0 (0.0) | 2119 (81.5) |
Other** | 645 (1.8) | 190 (7.3) |
Unknown | 10524 (29.6) | 292 (11.2) |
| ||
Region | ||
Asia-Pacific | 2121 (6.0) | 291 (11.2) |
Caribbean, Central and South America | 3404 (9.6) | 75 (2.9) |
North America | 14579 (41.0) | 0 (0.0) |
South Africa | 15457 (43.5) | 2235 (85.9) |
Unless otherwise specified.
For children, “Other” includes sexual behaviour (184), sexual abuse (2), blood transfusion (2) and breastfeeding (2).
Abbreviations: IQR – interquartile range; ART- antiretroviral therapy; IDU – injecting drug users